News

The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...
The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...
After soaring to success in the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) experienced a reversal of fortune ...
The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.
Moderna (NASDAQ: MRNA) stock represented the ticket to an investing win. The company brought its coronavirus vaccine from ...
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said on Tuesday that Moderna has agreed to a true ...
Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...